Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Assets (2018 - 2023)

Avai Bio's Assets history spans 5 years, with the latest figure at $291246.0 for Q4 2023.

  • For Q4 2023, Assets rose 2.23% year-over-year to $291246.0; the TTM value through Dec 2023 reached $291246.0, up 2.23%, while the annual FY2023 figure was $241460.0, N/A changed from the prior year.
  • Assets for Q4 2023 was $291246.0 at Avai Bio, up from $265061.0 in the prior quarter.
  • Across five years, Assets topped out at $816269.0 in Q3 2020 and bottomed at -$122491.0 in Q3 2019.
  • The 4-year median for Assets is $284890.0 (2022), against an average of $296881.3.
  • The largest annual shift saw Assets plummeted 291.41% in 2019 before it skyrocketed 3764.43% in 2020.
  • A 4-year view of Assets shows it stood at $166259.0 in 2019, then surged by 281.47% to $634232.0 in 2020, then plummeted by 55.08% to $284890.0 in 2022, then increased by 2.23% to $291246.0 in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Assets are $291246.0 (Q4 2023), $265061.0 (Q3 2023), and $274419.0 (Q2 2023).